Neuropace Inc (NPCE) is a medical devices company listed on US.
Latest reported NPCE revenue for 2026-06-30 was $22.8M. Net income was -$6.2M. Revenue was up 3.4% from 2026-03-31 to 2026-06-30. NPCE currently screens at market cap $312.2M.
Use this NPCE page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the NPCE quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the NPCE SEC filings page. Lician reads the product cache first so this HTML stays unique to Neuropace Inc even when a live quote feed is slow.
Latest cached year on this hub. Full NPCE income, balance, and cash tables.